BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6759515)

  • 1. Osteoblasts release osteoclasts from calcitonin-induced quiescence.
    Chambers TJ
    J Cell Sci; 1982 Oct; 57():247-60. PubMed ID: 6759515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of parathyroid hormone and calcitonin on the cytoplasmic spreading of isolated osteoclasts.
    Chambers TJ; Athanasou NA; Fuller K
    J Endocrinol; 1984 Sep; 102(3):281-6. PubMed ID: 6481285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term culture of disaggregated rat osteoclasts: inhibition of bone resorption and reduction of osteoclast-like cell number by calcitonin and PTHrP[107-139].
    Fenton AJ; Martin TJ; Nicholson GC
    J Cell Physiol; 1993 Apr; 155(1):1-7. PubMed ID: 8468357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of "escape" from calcitonin-induced inhibition of motility and resorption of disaggregated osteoclasts.
    Kanehisa J
    Bone; 1989; 10(2):125-9. PubMed ID: 2765310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin alters behaviour of isolated osteoclasts.
    Chambers TJ; Magnus CJ
    J Pathol; 1982 Jan; 136(1):27-39. PubMed ID: 7057295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoblast adherence and resorption activity of isolated osteoclasts on calcium sulphate hemihydrate.
    Sidqui M; Collin P; Vitte C; Forest N
    Biomaterials; 1995 Nov; 16(17):1327-32. PubMed ID: 8573671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of electromagnetic stimulation on the functional responsiveness of isolated rat osteoclasts.
    Shankar VS; Simon BJ; Bax CM; Pazianas M; Moonga BS; Adebanjo OA; Zaidi M
    J Cell Physiol; 1998 Sep; 176(3):537-44. PubMed ID: 9699506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of osteoclastic motility by prostaglandins I2, E1, E2 and 6-oxo-E1.
    Chambers TJ; Ali NN
    J Pathol; 1983 Mar; 139(3):383-97. PubMed ID: 6339702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoblast-osteoclast relationships in bone resorption: osteoblasts enhance osteoclast activity in a serum-free co-culture system.
    Teti A; Grano M; Colucci S; Cantatore FP; Loperfido MC; Zallone AZ
    Biochem Biophys Res Commun; 1991 Aug; 179(1):634-40. PubMed ID: 1652961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide regulates osteoclast activity via specific binding sites on both osteoclasts and osteoblasts.
    Lundberg P; Lie A; Bjurholm A; Lehenkari PP; Horton MA; Lerner UH; Ransjö M
    Bone; 2000 Dec; 27(6):803-10. PubMed ID: 11113391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning of an osteoblastic cell line involved in the formation of osteoclast-like cells.
    Yamashita T; Asano K; Takahashi N; Akatsu T; Udagawa N; Sasaki T; Martin TJ; Suda T
    J Cell Physiol; 1990 Dec; 145(3):587-95. PubMed ID: 1703173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
    Hill PA; Reynolds JJ; Meikle MC
    Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption.
    Britto JM; Fenton AJ; Holloway WR; Nicholson GC
    Endocrinology; 1994 Jan; 134(1):169-76. PubMed ID: 8275930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
    Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitonin Induces Bone Formation by Increasing Expression of Wnt10b in Osteoclasts in Ovariectomy-Induced Osteoporotic Rats.
    Hsiao CY; Chen TH; Chu TH; Ting YN; Tsai PJ; Shyu JF
    Front Endocrinol (Lausanne); 2020; 11():613. PubMed ID: 33013696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-dihydroxycholecalciferol and parathormone: effects on isolated osteoclast-like and osteoblast-like cells.
    Wong GL; Luben RA; Cohn DV
    Science; 1977 Aug; 197(4304):663-5. PubMed ID: 195343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strontium potently inhibits mineralisation in bone-forming primary rat osteoblast cultures and reduces numbers of osteoclasts in mouse marrow cultures.
    Wornham DP; Hajjawi MO; Orriss IR; Arnett TR
    Osteoporos Int; 2014 Oct; 25(10):2477-84. PubMed ID: 25048011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of the 3',5'-cyclic adenosine monophosphate and protein kinase C pathways on the response of isolated rat osteoclasts to calcitonin.
    Su Y; Chakraborty M; Nathanson MH; Baron R
    Endocrinology; 1992 Sep; 131(3):1497-502. PubMed ID: 1324163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice.
    Wennberg C; Hessle L; Lundberg P; Mauro S; Narisawa S; Lerner UH; Millán JL
    J Bone Miner Res; 2000 Oct; 15(10):1879-88. PubMed ID: 11028439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitonin inhibits SDCP-induced osteoclast apoptosis and increases its efficacy in a rat model of osteoporosis.
    Kuo YJ; Tsuang FY; Sun JS; Lin CH; Chen CH; Li JY; Huang YC; Chen WY; Yeh CB; Shyu JF
    PLoS One; 2012; 7(7):e40272. PubMed ID: 22792258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.